Stocks · Health care · Services-Commercial Physical & Biological Research

Absci Corp

ABSI Clue Score34
United States Fiscal year ends December CIK 0001672688 Results filed 11 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Mary T Szela
30 Jun 2026
Director
Buy
12,900
$11.54
$148.87K
Menelas N Pangalos
13 May 2026
Director
Buy
37,453
$5.36
$200.75K
Andreas Busch
12 Mar 2026
Chief Innovation Officer
Buy
100,000
$2.29
$229.00K
Menelas N Pangalos
27 Feb 2026
Director
Buy
75,095
$2.74
$205.76K
Houten Frans Van
5 Dec 2025
Director
Buy
40,000
$3.72
$148.80K
Todd Bedrick
22 Sep 2025
SVP, CAO
Buy
10,000
$2.70
$27.00K
Menelas N Pangalos
22 Sep 2025
Director
Buy
95,785
$2.66
$254.79K
Andreas Busch
28 Jul 2025
Chief Innovation Officer
Buy
50,000
$3.04
$152.00K
Redmile Group, LLC
1 Mar 2024
Director
Buy indirect
222,222
$4.50
$1,000.00K
Sarah Korman
9 Feb 2022
General Counsel
Buy
4,250
$7.96
$33.83K
Todd Bedrick
20 Jan 2022
VP, Ccpao
Buy
2,000
$7.50
$15.00K
Sean McClain
19 Jan 2022
President and Chief Executive
Buy
7,155
$6.92
$49.51K
Todd Bedrick
26 Jul 2021
VP, Ccpao
Buy
1,000
$16.00
$16.00K
Eli Casdin
26 Jul 2021
Director
Buy indirect
1,562,500
$16.00
$25.00M
Casdin Partners Master Fund, L.P.
26 Jul 2021
Director
Buy
1,562,500
$16.00
$25.00M
Zachariah Jonasson
26 Jul 2021
Director
Buy
9,000
$16.00
$144.00K
Sarah Korman
26 Jul 2021
General Counsel
Buy
10,000
$16.00
$160.00K
Sean McClain
26 Jul 2021
President and Chief Executive
Buy
600
$16.00
$9.60K
Karen K McGinnis
26 Jul 2021
Director
Buy
15,000
$16.00
$240.00K
Redmile Group, LLC
26 Jul 2021
Director
Buy indirect
1,875,000
$16.00
$30.00M

What was left out

Form 4 filings counted 132
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 38,100,156
History held since 28 Jul 2021